Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v1-EN
Language English English
Date Updated 2019-04-04 2018-01-02
Drug Identification Number 02229418 02229418
Brand name NAROPIN NAROPIN
Common or Proper name Naropin® 10mg/mL 5x10mL SU Polyamp® Duofit® Naropin® 10mg/mL 5x10mL SU Polyamp® Duofit®
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 5x10mL 5
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug. Delay in shipping of the drug.
Anticipated start date 2018-03-01 2018-03-01
Actual start date 2018-03-01
Estimated end date 2019-04-01 Unknown
Actual end date 2019-04-03
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments